Time effects of food intake on the pharmacokinetics and pharmacodynamics of quazepam

British Journal of Clinical Pharmacology

Volumn 55, Issue 4, 2003, Pages 382-388

  Yasui Furukori, Norio ^a   Takahata, Takenori ^a   Kondo, Tsuyoshi ^a   Mihara, Kazuo ^a   Kaneko, Sunao ^a   Tateishi, Tomonori ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Food effect; Pharmacokinetics; Quazepam; Time interval

Indexed keywords

7 CHLORO 5 (2 FLUOROPHENYL) 1,3 DIHYDRO 1 (2,2,2 TRIFLUOROETHYL) 2H 1,4 BENZODIAZEPIN 2 ONE; QUAZEPAM;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; EATING DISORDER; EXPERIMENTAL TEST; FOOD DRUG INTERACTION; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; MALE; MEAL; METABOLITE; NORMAL HUMAN; PARAMETER; PHARMACODYNAMICS; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SCALE UP; TIME; VISUAL ANALOG SCALE; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; CROSS-OVER STUDIES; EATING; FASTING; FATIGUE; FOOD-DRUG INTERACTIONS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PSYCHOMOTOR PERFORMANCE; THINKING; TIME FACTORS;

EID: 0038746651     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2003.01775.x     Document Type: Article

References (33)

1. Kales A. Quazepam hypnotic efficacy and side effects. Pharmacotherapy 1994; 10: 1-12.
2. Mendels J. Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients. J Clin Psychiatry 55: 60-65.
3. Chung M, Hilbert JM, Gural RP, Radwanski E, Symchowicz S, Zampaglione N. Multiple-dose quazepam kinetics. Clin Pharmacol Ther 1984; 35: 520-524.
4. Hilbert JM, Chung M, Maier G, Gural R, Symchowicz S, Zampaglione N. Effect of sleep on quazepam kinetics. Clin Pharmacol Ther 1984; 36: 99-104.
5. Welty DF, Siedlik PH, Posvar EL, Selen A, Sedman AJ. The temporal effect of food on tacrine bioavailability. J Clin Pharmacol 1994; 34: 985-988.
6. Pao LH, Zhou SY, Cook C, et al. Reduced systemic availability of an antiarrhythmic drug, bidisomide, with meal co-administration: relationship with region-dependent intestinal absorption. Pharm Res 1998; 15: 221-227.
7. Nyberg L, Kennedy BM. Pharmacokinetics of terbutaline given in slow-release tablets. Eur J Respir Dis 1984; 134 (Suppl): 119-139.
8. Morgan T. Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin Pharmacokinet 1994; 26: 335-346.
9. Lindholm A, Henricsson S, Dahlqvist R. The effect of food and bile acid administration on the relative bioavailability of cyclosporin. Br J Clin Pharmacol 1990; 29: 541-548.
10. Charman WN, Porter CJ, Mithani S, Dressman JB. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 1997; 86: 269-282.
11. Efthymiopoulos C, Bramer SL, Maroli A. Effect of food and gastric pH on the bioavailability of grepafloxacin. Clin Pharmacokinet 1997; 33 (Suppl 1): 18-24.
12. Lee LJ, Hafkin B, Lee ID, Hoh J, Dix R. Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects. Antimicrob Agents Chemother 1997; 41: 2196-2200.
13. Vincent J, Teng R, Dogolo LC, Willavize SA, Friedman HL. Effect of trovafloxacin, a new fluoroquinolone antibiotic, on the steady-state pharmacokinetics of theophylline in healthy volunteers. J Antimicrob Chemother 1997; 39 (Suppl B): 81-86.
14. Emori H, Yamamoto K, Yokohama S, Nishihata T. Bioavailability of bropirimine 250 mg tablet in dogs: effect of food. J Pharm Pharmacol 1995; 47: 822-826.
15. Lennernas H, Fager G. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharmacokinet 1997; 32: 403-425.
16. Hughes GS, Heald DL, Barker KB, et al. The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil. Clin Pharmacol Ther 1989; 46: 674-685.
17. Shinkuma D, Hamaguchi T, Kobayashi M, Yamanaka Y, Mizuno N. Effects of food intake on the bioavailability of sulpiride from AEA film-coated tablet having a pH-dependent dissolution characteristic in normal or drug-induced achlorhydric subjects. Int J Clin Pharmacol Ther Toxicol 1991; 29: 303-309.
18. TenHoor CN, Bakatselou V, Dressman J. Solubility of mefenamic acid under simulated fed- and fasted-state conditions. Pharm Res 1991; 8: 1203-1205.
19. McLean AJ, McNamara PJ, duSouich P, Gibaldi M, Lalka D. Food, splanchnic blood flow, and bioavailability of drugs subject to first-pass metabolism. Clin Pharmacol Ther 1978; 24: 5-10.
20. McLean AJ, Isbister C, Bobik A, Dudley FJ. Reduction of first-pass hepatic clearance of propranolol by food. Clin Pharmacol Ther 1981; 30: 31-34.
21. Aoki S, Ando H, Ishii M, Ida K, Watanabe S, Ozawa H. Evaluation of the correlation between in vivo and in vitro release. Effect of the force of contraction and food on drug release. Biol Pharm Bull 1994; 17: 291-295.
22. Humberstone AJ, Porter CJ, Charman WN. A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine. J Pharm Sci 1996; 85: 525-529.
23. Miles C, Dickson P, Rana K, Lippert C, Fleisher D. CCK antagonist pre-treatment inhibits meal-enhanced drug absorption in dogs. Regul Pept 1997; 68: 9-14.
24. Williams L, Davis JA, Lowenthal DT. The influence of food on the absorption and metabolism of drugs. Med Clin North Am 1993; 77: 815-829.
25. Greenblatt DJ, Shader RI, Harmatz JS, Franke K, Koch-Weser J. Absorption rate, blood concentrations, and early response to oral chlordiazepoxide. Am J Psychiatry 1977; 134: 559-562.
26. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology 1973; 10: 431-436.
27. Zampaglione N, Hilbert JM, Ning J, Chung M, Gural R, Symchowicz S. Disposition and metabolic fate of 14C-quazepam in man. Drug Metab Dispos 1985; 13: 25-29.
28. Fleisher D, Li C, Zhou Y, Pao LH, Karim A. Drug meal and formulation interactions influencing drug absorption after oral administration. Clinical implications. Clin Pharmacokinet 1999; 36: 233-254.
29. Singh BN. Effects of food on clinical pharmacokinetics. Clin Pharmacokinet 1999; 37: 213-255.
30. Zhi J, Rakhit A, Patel IH. Effects of dietary fat on drug absorption. Clin Pharmacol Ther 1995; 58: 487-491.
31. Yasui-Furukori N, Kondo T, Takahata T, Mihara K, Ono S, Kaneko S, Tateishi T. Effect of dietary fat content in meals on pharmacokinetics of quazepam. J. Clin Pharmacol.
32. Ameer B, Weintraub RA. Drug interactions with grapefruit juice. Clin Pharmacokinet 1997; 33: 103-121.
33. Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet 2000; 38: 41-57.